Appili Therapeutics Inc.
APLIF
$0.0272
$0.00124.62%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -112.00K | -728.10K | -1.15M | -1.97M | -1.93M |
| Total Depreciation and Amortization | 2.50K | 2.60K | 2.60K | 1.20K | 1.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.90K | -19.30K | 287.30K | 932.60K | 199.30K |
| Change in Net Operating Assets | 241.80K | 568.00K | -643.60K | 213.20K | 1.02M |
| Cash from Operations | 186.10K | -176.80K | -1.51M | -820.10K | -705.30K |
| Capital Expenditure | 0.00 | 0.00 | -22.10K | -2.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -2.60K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -22.10K | -4.90K | 0.00 |
| Total Debt Issued | 0.00 | 150.00K | 150.00K | 2.50M | -- |
| Total Debt Repaid | -28.10K | -19.80K | -23.20K | -22.30K | -21.70K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.80K | -18.50K | -19.20K | -320.50K | -20.50K |
| Cash from Financing | -33.70K | 83.30K | 80.10K | 1.59M | -31.10K |
| Foreign Exchange rate Adjustments | -100.00 | 300.00 | 500.00 | -1.90K | 1.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 152.30K | -93.20K | -1.45M | 768.00K | -735.30K |
